Skip to content
Open access

Assessment of stereotypies in autism spectrum disorder

Oct 2026 · ANPAbstract_CBN26 · 0 citations

Abstract

Background: Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by deficits in communication and social interaction, associated with restricted and repetitive patterns of behavior, with varying levels of support. Its clinical heterogeneity, presence of comorbidities, and family impact make it highly relevant in neurology, particularly regarding early diagnosis and multidisciplinary management. Objective: This study evaluated stereotypies, medication use, and the epidemiological profile of children with ASD treated at the Associação de Pais do Espectro Autista de Sorocaba (APEAS). Methods: This was a descriptive cross-sectional study involving 32 parents or caregivers of children with a confirmed ASD diagnosis. A structured questionnaire was applied, including sociodemographic and perinatal data, family history, age at first symptom perception, age and setting of diagnosis, level of support, schooling, medication and therapies in use, and the Repetitive Behavior Scale-Revised (RBS-R). Descriptive statistical analysis was performed. Results: There was a predominance of males (75%), consistent with the literature. Most children were born between 2018 and 2019 and resided in the same municipality. Mothers accounted for 78.1% of respondents. Approximately 46.9% of families received social benefits, indicating socioeconomic vulnerability. Most children were born at term (81.3%), although 31.2% had neonatal complications. Early signs were perceived before two years of age in 65.6% of cases, but diagnosis was concentrated between two and five years. More than half were diagnosed through the public health system, mainly by neuropediatricians. Level 2 support predominated (56.3%). School attendance was high (96.9%), yet 80.6% required a therapeutic aide and had experienced difficulties remaining in school. Family aggregation of ASD (25%), ADHD, epilepsy, and depression was observed. Regarding pharmacotherapy, 81.2% used medication, mainly risperidone, fluoxetine, aripiprazole, and cannabidiol, prescribed for sleep disturbances, inattention, agitation, and anxiety. Some cases involved polypharmacy and long-term use, with reported weight gain, although 87% of caregivers noted behavioral improvement. Conclusion: All children received multidisciplinary follow-up, particularly psychology and occupational therapy, generally initiated after three years of age. The RBS-R revealed predominantly mild to moderate stereotypies and higher frequency of cognitive rigidity. The findings indicate moderate functional impairment, high demand for educational and therapeutic support, and frequent medication use, reinforcing the importance of early diagnosis and intervention.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.